Skip to Main Content
Try STAT+ TODAY
Trending:
Pharmalot
Health
Biotech
First Opinion
Subscribe Now To access exclusive content, subscribe to STAT+
View Latest View the latest STAT+ stories
Biotech
STAT+

Roche pharmaceuticals CEO Bill Anderson to step down after four-year tenure

  • Jason Mast

By Jason Mast Dec. 12, 2022

Reprints
Roche HQ
SEBASTIEN BOZON/AFP via Getty Images

Roche announced Monday that Bill Anderson, CEO of its pharmaceuticals division, will step down after nearly four years at the helm.

His last day will be Dec. 31, Roche said, as Anderson leaves to “pursue opportunities outside of Roche.” A successor will be appointed by March, the company added. 

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

About the Author Reprints

Jason Mast

Jason Mast

General Assignment Reporter

Jason Mast is a general assignment reporter at STAT focused on the science behind new medicines and the systems and people that decide whether that science ever reaches patients.

Tags

Create a display name to comment

This name will appear with your comment

Inside the fall of star MIT scientist David Sabatini
Inside the fall of star MIT scientist David Sabatini
Combination of two drugs can help treat methamphetamine addiction…
Combination of two drugs can help treat methamphetamine addiction for some, new clinical trial data shows 
Why fentanyl is deadlier than heroin, in a single…
Why fentanyl is deadlier than heroin, in a single photo
FDA may not always require post-approval trials to be…
FDA may not always require post-approval trials to be enrolled before accelerated approvals
Gene therapy can transform life for people with hemophilia.…
Gene therapy can transform life for people with hemophilia. But some patients don’t want it.
U.K. lawmakers urge Pfizer not to raise the price…
U.K. lawmakers urge Pfizer not to raise the price of its Covid-19 vaccine

Recommended Stories